Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease

Journal of Laryngology and Otology

Volumn 125, Issue 2, 2011, Pages 138-141

  Al Dousary, S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Cochlear Implant; Corticosteroids; Hearing Loss; Melanocytes; Uveitis; Vertigo; Vitiligo; Vogt Koyanagi Harada Disease

Indexed keywords

ANTIHISTAMINIC AGENT; CALCIUM; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; AUDITORY SYSTEM; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; HEADACHE; HEARING LOSS; HERPES ZOSTER; HIRSUTISM; HUMAN; HYPERTENSION; IMPLANTATION; MALE; OSTEOPOROSIS; PERCEPTION DEAFNESS; SCHOOL CHILD; TINNITUS; TREATMENT DURATION; UVEITIS; VERTIGO; VESTIBULAR DISORDER; VESTIBULAR SYSTEM; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; CHILD; COCHLEAR IMPLANTATION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEARING LOSS, BILATERAL; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; TIME FACTORS; UVEOMENINGOENCEPHALITIC SYNDROME; YOUNG ADULT;

EID: 79951722408     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215110001817     Document Type: Article

References (18)

1. Ibanez HE, Grand MG, Meredith TA, Wippold FJ. Magnetic resonance imaging findings in Vogt-Koyanagi-Harada Disease. Retina 1994;14:164-8 (Pubitemid 24195746)
2. Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol 1990;108:1421-6 (Pubitemid 20344697)
3. Sheu SJ, Kou HK, Chen JF. Prognostic factors for Vogt- Koyanagi-Harada Disease. J Chin Med Assoc 2003;66:148-54
4. Panitrungroung T, Kulthanan K, Chuenkongkaew W. Vogt- Koyanagi-Harada syndrome: a case report and literature review. Thai J Dermatol 1999;15:208-14
5. Kahn M, Pepose JS, Green WR, Miller J, Foos RY. Immunocytologic findings in a case of Vogt-Koyanagi-Harada syndrome. Ophthalmology 1993;100:1191-8 (Pubitemid 23226817)
6. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt- Koyanagi-Harada disease. J Immunol 2000;165:7323-9 (Pubitemid 32001213)
7. Read RW, Rao NA. Utility of existing Vogt-Koyanagi-Harada syndrome diagnostic criteria at initial evaluation of the individual patient: a retrospective analysis. Ocul Immunol Inflamm 2000;8:227-34 (Pubitemid 32174743)
8. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L et al. Perspective: revised criteria for Vogt- Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52 (Pubitemid 32422124)
9. Yamaki K, Sakuraqi S. Application of revised diagnostic criteria for patients with Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 2005;49:143-8 (Pubitemid 40603161)
10. Hayasaka S, Okabe H, Takahashi J. Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 1982;218:9-13 (Pubitemid 12247495)
11. Freeman WR, Chavis PS, Tabbara KF. Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 1998;76:723-6 (Pubitemid 28563146)
12. Yoshimoto Y. Otoneurological observation and classification of Harada's disease presenting with aural symptoms, especially vertigo. Acta Otolaryngol (Stockh) 1995;519(suppl):114-17
13. Seals RL, Rise EN. Vogt-Koyanagi-Harada syndrome. Arch Otolaryngol Head Neck Surg 1967;86:419-23
14. Kimura H, Ohashi N, Aso S, Watanabe Y. Clinical study of the role of melanocytes in the inner ear of patients with Harada's disease. ORL J Otorhinolaryngol Relat Spec 1996;58:233-7 (Pubitemid 26305896)
15. Maxwell ON. Hearing loss in uveitis. Arch Otolaryngol 1963; 78:138-42
16. Read RW, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi- Harada disease. Am J Ophthalmol 2006;42:119-24 (Pubitemid 43964911)
17. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporine A therapy in the treatment of interocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 1983;96:275-82 (Pubitemid 13000969)
18. Wakatsuki Y, Kogure M, Takahashi Y, Oguro Y. Combination therapy with cyclosporine A and steroid in severe case of Vogt-Koyanagi-Harada's disease. Jpn Ophthalmol 1988;32: 358-60